Glenmark shares rise after US arm launches cancer therapy drug
CNBC-TV18

Glenmark shares rose after its US arm launched generic Axitinib Tablets, an authorized version of Pfizer's INLYTA.
Glenmark Pharmaceuticals announced that its US arm has launched generic
Axitinib Tablets, an authorized version of Pfizer's cancer drug INLYTA,
following regulatory approval.





